HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. announced the engagement of BTIG, a global financial services firm, as their financial advisor. The scope of this engagement includes advisory and assistance in evaluating strategic and financing options available to the company.
BTIG will also assist in the identification, evaluation, and negotiation of potential acquisition targets for the expanding HOPE network of clinics. Furthermore, the firm will advise on equity and debt financing structures to support these acquisitions.
This engagement follows the recent announcement of $27 million in funding for HOPE clinic acquisitions, which the company intends to leverage with proposed bank debt and similar instruments. The partnership with BTIG is expected to accelerate the company's business strategy of assembling a global network of Interventional Psychiatry Clinics.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.